InvestorLens

BMRN — BIOMARIN PHARMACEUTICAL INC

Public company

Sign in to save7 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BMRN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
88
Institutional Conviction
Strong accumulation · 7 buying vs 1 selling last quarter
77
Macro Tailwind
Macro conditions are mixed for this sector
52
Why? — Evidence & Confidence ▾

Of 8 tracked investors who changed their BMRN position last quarter, 7 bought and 1 sold (88% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence
  • +7 tracked investors added or increased positions last quarter (Howard Marks, Howard Marks, Paul Tudor Jones, …)
  • +7 tracked investors reported holding BMRN at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About BIOMARIN PHARMACEUTICAL INC (BMRN)

BIOMARIN PHARMACEUTICAL INC (BMRN) appears in the most recent 13F filings of 7 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $399M. Across recent filings, tracked investors recorded 13 new positions, 0 increased, 2 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BMRN

87
/100
Strong Institutional Accumulation
Added / Increased13
Reduced2
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track BMRN

47
/100
Moderate Interest
7investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

BMRN Ownership Composition

How BIOMARIN PHARMACEUTICAL INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
87% of tracked value
Institutions
7
tracked investors
Total Reported
$977.6M
combined 13F value
Sectors2
  • Other87.0%
  • Hedge Funds13.0%
Other(5)
87.0%
Hedge Funds(2)
13.0%

Tracked investors reporting BMRN

  • Andreas HalvorsenMar 31, 2026
    Viking Global Investors
    Shares
    7.1M
    Value
    $398.9M
    % Portfolio
    1.12%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    4.7M
    Value
    $265.4M
    % Portfolio
    0.04%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    3.1M
    Value
    $173.3M
    % Portfolio
    0.07%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    1.3M
    Value
    $73.4M
    % Portfolio
    0.09%
  • Howard MarksMar 31, 2026
    Oaktree Capital Management
    Shares
    56M
    Value
    $54M
    % Portfolio
    0.83%
  • Ray DalioMar 31, 2026
    Bridgewater Associates
    Shares
    206.9K
    Value
    $11.7M
    % Portfolio
    0.05%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    14.8K
    Value
    $836.1K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold BMRN?
7 tracked institutional investors disclosed a position in BMRN (BIOMARIN PHARMACEUTICAL INC) in their most recent 13F filing.
Who is the largest institutional holder of BMRN?
Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in BMRN, valued at $399M.
Did institutional ownership of BMRN increase or decrease?
Across recent 13F filings, tracked investors recorded 13 new positions, 0 increased, 2 reduced, and 0 fully exited BMRN.
Where does this BMRN ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.